{"transactions":[{"id":3513555,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2026-09-08T20:06:19.000Z","date":"2026-09-03","kind":"other","planned":false,"acquired":false,"shares":4587,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.96,"exercise_date":"2022-12-08","expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":4587},"source":{"system":"sec-edgar","filing":"0001214659-26-011475","document":"marketforms-73943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1960154/000121465926011475/marketforms-73943.xml","form_type":"4"}},{"id":3513554,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:06:19.000Z","date":"2026-09-03","kind":"other","planned":false,"acquired":true,"shares":4587,"price":0.96,"value":4403.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share."}],"balance_after":206833,"source":{"system":"sec-edgar","filing":"0001214659-26-011475","document":"marketforms-73943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1960154/000121465926011475/marketforms-73943.xml","form_type":"4"}},{"id":788314,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-07T21:32:25.000Z","date":"2026-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":72734,"price":4.18,"value":304028.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (\"PSUs\") previously granted to the Reporting Person."}],"balance_after":202246,"source":{"system":"sec-edgar","filing":"0001214659-26-005748","document":"marketforms-73070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926005748/marketforms-73070.xml","form_type":"4"}},{"id":809525,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-13T19:53:34.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 was filed late due to an inadvertent administrative oversight."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. \"Performance Price\" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period)."}],"balance_after":60000,"derivative":{"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-26-004595","document":"marketforms-72927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926004595/marketforms-72927.xml","form_type":"4"}},{"id":848348,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:50:43.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":42500,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001214659-26-003141","document":"marketforms-72467.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003141/marketforms-72467.xml","form_type":"4"}},{"id":848347,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:50:43.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":45791,"price":4.173,"value":191085.843,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":274980,"source":{"system":"sec-edgar","filing":"0001214659-26-003141","document":"marketforms-72467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003141/marketforms-72467.xml","form_type":"4"}},{"id":848346,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:50:43.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":320771,"source":{"system":"sec-edgar","filing":"0001214659-26-003141","document":"marketforms-72467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003141/marketforms-72467.xml","form_type":"4"}},{"id":1016387,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-10-17T18:01:41.000Z","date":"2025-10-15","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 10, 2021 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.1027,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-25-015048","document":"marketforms-71051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925015048/marketforms-71051.xml","form_type":"4"}},{"id":1016386,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-10-17T18:01:41.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":67575,"price":7.01,"value":473700.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":240771,"source":{"system":"sec-edgar","filing":"0001214659-25-015048","document":"marketforms-71051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925015048/marketforms-71051.xml","form_type":"4"}},{"id":1016385,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-10-17T18:01:41.000Z","date":"2025-10-15","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":3.1027,"value":77567.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."}],"balance_after":308346,"source":{"system":"sec-edgar","filing":"0001214659-25-015048","document":"marketforms-71051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925015048/marketforms-71051.xml","form_type":"4"}},{"id":1045639,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-09-08T23:06:55.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on August 5, 2022 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.7063,"expiration_date":"2032-08-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-25-013493","document":"marketforms-70687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013493/marketforms-70687.xml","form_type":"4"}},{"id":1045638,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-09-08T23:06:55.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on August 9, 2019 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.15,"expiration_date":"2029-08-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-25-013493","document":"marketforms-70687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013493/marketforms-70687.xml","form_type":"4"}},{"id":1045637,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-08T23:06:55.000Z","date":"2025-09-04","kind":"sale","planned":true,"acquired":false,"shares":62180,"price":5,"value":310900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":283346,"source":{"system":"sec-edgar","filing":"0001214659-25-013493","document":"marketforms-70687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013493/marketforms-70687.xml","form_type":"4"}},{"id":1045636,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-08T23:06:55.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":0.7063,"value":17657.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."}],"balance_after":345526,"source":{"system":"sec-edgar","filing":"0001214659-25-013493","document":"marketforms-70687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013493/marketforms-70687.xml","form_type":"4"}},{"id":1045635,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-08T23:06:55.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":3.15,"value":78750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."}],"balance_after":320526,"source":{"system":"sec-edgar","filing":"0001214659-25-013493","document":"marketforms-70687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925013493/marketforms-70687.xml","form_type":"4"}},{"id":1211729,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-11T21:48:57.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":40000,"derivative":{"exercise_price":2.65,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001214659-25-004227","document":"marketforms-68571.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004227/marketforms-68571.xml","form_type":"4"}},{"id":1211728,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:48:57.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2182,"price":2.54,"value":5542.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":295526,"source":{"system":"sec-edgar","filing":"0001214659-25-004227","document":"marketforms-68571.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004227/marketforms-68571.xml","form_type":"4"}},{"id":1211727,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:48:57.000Z","date":"2025-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":7997,"price":2.65,"value":21192.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":297708,"source":{"system":"sec-edgar","filing":"0001214659-25-004227","document":"marketforms-68571.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004227/marketforms-68571.xml","form_type":"4"}},{"id":1211726,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:48:57.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":7361,"price":2.65,"value":19506.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":305705,"source":{"system":"sec-edgar","filing":"0001214659-25-004227","document":"marketforms-68571.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004227/marketforms-68571.xml","form_type":"4"}},{"id":1211725,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:48:57.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":313066,"source":{"system":"sec-edgar","filing":"0001214659-25-004227","document":"marketforms-68571.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004227/marketforms-68571.xml","form_type":"4"}},{"id":1348937,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-11-27T21:24:09.000Z","date":"2024-11-26","kind":"sale","planned":false,"acquired":false,"shares":44,"price":4.865,"value":214.06,"ownership":{"direct":false,"nature":"by spouse IRA"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares owned by spouse who shares Ms. Jung's household. Ms. Jung disclaims beneficial ownership of the shares held by her spouse, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16(a) of the Securities Exchange Act of 1940, as amended, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-24-019685","document":"marketforms-67449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924019685/marketforms-67449.xml","form_type":"4"}},{"id":1393824,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Common Stock","published_at":"2024-10-02T18:14:55.000Z","date":"2024-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":14120,"price":4.88,"value":68905.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 ."}],"balance_after":233066,"source":{"system":"sec-edgar","filing":"0001214659-24-017008","document":"marketforms-67098.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924017008/marketforms-67098.xml","form_type":"4/A","original_submission_date":"2024-03-12"}},{"id":1580505,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Common Stock","published_at":"2024-03-12T17:46:03.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1132,"price":4.88,"value":5524.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":237754,"source":{"system":"sec-edgar","filing":"0001214659-24-004390","document":"marketforms-65150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004390/marketforms-65150.xml","form_type":"4"}},{"id":1580504,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Common Stock","published_at":"2024-03-12T17:46:03.000Z","date":"2024-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":8300,"price":4.88,"value":40504.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":238886,"source":{"system":"sec-edgar","filing":"0001214659-24-004390","document":"marketforms-65150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004390/marketforms-65150.xml","form_type":"4"}},{"id":1583728,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-03-11T14:35:25.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":50625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":50625,"derivative":{"exercise_price":5.68,"expiration_date":"2024-03-07","underlying":"Common Stock","underlying_shares":50625},"source":{"system":"sec-edgar","filing":"0001214659-24-004304","document":"marketforms-65134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004304/marketforms-65134.xml","form_type":"4"}},{"id":1583727,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Common Stock","published_at":"2024-03-11T14:35:25.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":101250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":247186,"source":{"system":"sec-edgar","filing":"0001214659-24-004304","document":"marketforms-65134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004304/marketforms-65134.xml","form_type":"4"}},{"id":1583726,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Common Stock","published_at":"2024-03-11T14:35:25.000Z","date":"2023-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The original Form 3, filed on 1/1/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares vested that occurred on 3/10/22 as a total of 4,663 shares vested and owned when in fact 3,173 shares of the Issuer's common stock were owned, net of taxes withheld. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 1,490 shares reflecting share withheld for the payment of taxes."}],"balance_after":145936,"source":{"system":"sec-edgar","filing":"0001214659-24-004304","document":"marketforms-65134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004304/marketforms-65134.xml","form_type":"4"}},{"id":1811757,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Performance Stock Units","published_at":"2023-08-09T20:30:17.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based stock unit (\"PSU\") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance-based stock unit (\"PSU\") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period."}],"balance_after":55000,"derivative":{"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001214659-23-010920","document":"marketforms-61883.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465923010920/marketforms-61883.xml","form_type":"4"}},{"id":1902270,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Performance Stock Units","published_at":"2023-05-05T20:00:20.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of Aquestive (\"Company\") common stock. The PSUs have a three-year Performance Period, and, to the extent\nearned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the\nlast day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results\nof the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior\nto and including the last calendar day of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of Aquestive (\"Company\") common stock. The PSUs have a three-year Performance Period, and, to the extent\nearned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the\nlast day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results\nof the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior\nto and including the last calendar day of the Performance Period."}],"balance_after":55000,"derivative":{"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001214659-23-006554","document":"marketforms-61238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465923006554/marketforms-61238.xml","form_type":"4"}},{"id":1960667,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":49071,"kind":"person","name":"Jung Cassie","position":1,"cik":"0001960154","reported_name":"Jung Cassie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Common Stock","published_at":"2023-03-09T20:07:32.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":146747,"source":{"system":"sec-edgar","filing":"0001214659-23-003693","document":"marketforms-59531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465923003693/marketforms-59531.xml","form_type":"4"}}]}